Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXELON CORP Director's Dealing 2025

Feb 4, 2025

30044_dirs_2025-02-04_2c57dc9f-5df8-4377-a856-8626f21fc932.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELON CORP (EXC)
CIK: 0001109357
Period of Report: 2025-02-03

Reporting Person: Kleczynski Robert A (SVP, Controller & Tax)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-02-03 Common Stock M 1233 Acquired 24272 Direct
2025-02-03 Common Stock M 1422 Acquired 25694 Direct
2025-02-03 Common Stock M 1624 Acquired 27318 Direct
2025-02-03 Common Stock M 5749 Acquired 33067 Direct
2025-02-03 Common Stock F 3108 $40.57 Disposed 29959 Direct
2025-02-03 Common Stock D 2032 $40.57 Disposed 27927 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-02-03 2022 Restricted Stock Units $ M 1233 Disposed Common Stock (1233) Direct
2025-02-03 2023 Restricted Stock Units $ M 1422 Disposed Common Stock (1422) Direct
2025-02-03 2024 Restricted Stock Units $ M 1624 Disposed Common Stock (1624) Direct
2025-02-03 2025 Restricted Stock Units $ A 6101 Acquired Common Stock (6101) Direct
2025-02-03 2022-2024 Performance Shares $ A 5749 Acquired Common Stock (5749) Direct
2025-02-03 2022-2024 Performance Shares $ M 5749 Disposed Common Stock (5749) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Retention RSUs $ Common Stock (22258) 22258 Direct
Deferred phantom share equivalents $ Common Stock (1736) 1736 Direct

Footnotes

F1: Restricted stock unit (RSU) award granted under the Exelon Long-Term Incentive Plan (LTIP). Award vests in 1/3 increments at the January or February meeting of the Exelon Talent Management and Compensation Committee (TMCC) with each RSU representing the right to receive one share of Exelon common stock upon vesting. The award accrues additional RSUs each quarter through automatic dividend reinvestment, and the additional RSUs vest on the same schedule as the underlying award.

F2: Performance share award granted under the LTIP for the three-year performance period referenced in Column 1 based upon the TMCC's determination of performance achieved for the period. Each performance share represents the right to receive one share or the cash equivalent of one share pursuant to the LTIP's terms with respect to individual stock ownership levels. Performance share awards vest immediately on their grant date.

F3: Balance at the time of this vesting includes 49 additional shares acquired through automatic dividend reinvestment during 2024.

F4: Balance at the time of this vesting includes 113 additional shares acquired through automatic dividend reinvestment during 2024.

F5: Balance at the time of this vesting includes 194 additional shares acquired through automatic dividend reinvestment during 2024.

F6: Restricted stock unit (RSU) award granted under the Exelon LTIP on February 25, 2022. Each RSU represents the right to receive one share of Exelon common stock upon vesting. The award accrues additional RSUs each quarter through automatic dividend reinvestment and the additional RSUs vest on the same schedule as the underlying award. The award will cliff vest on February 25, 2025.

F7: Balance includes 887 additional shares acquired through automatic dividend reinvestment during 2024.

F8: Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. The stock fund is a unitized fund that consists of both Exelon common stock and short-term liquid investments. Units of the fund are acquired through quarter-end contributions and dividend reinvestment and will be settled for cash upon the termination of the reporting person. The balance of phantom share equivalents may fluctuate due to changes in the value of the fund units.

F9: Balance as of January 31, 2025. Balance includes 65 additional phantom share equivalents acquired during 2024 through automatic dividend reinvestment.